Assessing the Protective Efficacy of Antibodies to the HIV Gp41 Region by Active Vaccination

Retrovirology - United Kingdom
doi 10.1186/1742-4690-9-s2-p37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search